Sofwave Medical Ltd. (IL:SOFW)
TASE:SOFW
Want to see IL:SOFW full AI Analyst Report?
SOFW Stock Chart & Stats
2800.00
-0.53(-3.47%)
At close: 4:00 PM EST
2800.00
-0.53(-3.47%)
Day’s Range― - ―
52-Week Range1,599.00 - 4,644.00
Previous CloseN/A
Volume25.73K
Average Volume (3M)26.78K
Market Cap
₪1.54B
Enterprise Value482.47M
Total Cash (Recent Filing)₪35.28M
Total Debt (Recent Filing)₪1.12M
Price to Earnings (P/E)51.4
Beta0.48
Next Earnings
May 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)37.00
Shares Outstanding36,123,390
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)9.34
Price to Sales (P/S)3.22
P/FCF Ratio21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Consumable RevenueSofwave's business model includes recurring revenue from procedure consumables and service, tying revenue to utilization of its installed base. That creates a durable, higher-margin revenue stream that supports cash conversion as system placements grow and stabilizes revenues versus one-time equipment sales.
2025 Profitability InflectionThe 2025 inflection to revenue growth and positive operating profit/net income demonstrates that operating leverage can flip the business to sustainable profitability. If management sustains those unit economics, future incremental placements and consumable attach rates should convert to durable cash generation and reinvestment capacity.
Conservative LeverageA low-debt balance sheet gives Sofwave financial flexibility to fund R&D, commercial expansion, or working capital without heavy interest burdens. Conservative leverage reduces solvency risk during growth or adoption cycles and improves the company's ability to sustain investments needed to deepen market penetration.
Bears Say
Multi-year Prior LossesSofwave posted losses and negative operating cash flow for several years through 2024. That history raises execution risk: a single-year swing to profit can reflect timing or one-off factors. Sustaining margin improvements requires consistent demand, pricing discipline, and operational control over several cycles.
Historic Cash-flow VolatilityWhile cash flow was strongly positive in 2025, the prior multi-year negative trend indicates volatility tied to adoption and capital sales timing. This variability can constrain planning, make reinvestment or shareholder returns episodic, and requires proving persistent positive operating cash flow across future periods.
Scale And Consistency RiskRapid revenue scaling from a small base can mask concentration and operational leverage limits. With a compact organization and recent inconsistent profitability, Sofwave must sustain system placements and procedure volumes; any slowdown in adoption or competitive pressure could quickly reverse margin gains.
Sofwave News
SOFW FAQ
What was Sofwave Medical Ltd.’s price range in the past 12 months?
Sofwave Medical Ltd. lowest stock price was 1599.00 and its highest was 4644.00 in the past 12 months.
What is Sofwave Medical Ltd.’s market cap?
Sofwave Medical Ltd.’s market cap is ₪1.54B.
When is Sofwave Medical Ltd.’s upcoming earnings report date?
Sofwave Medical Ltd.’s upcoming earnings report date is May 13, 2026 which is in 12 days.
How were Sofwave Medical Ltd.’s earnings last quarter?
Sofwave Medical Ltd. released its earnings results on Mar 17, 2026. The company reported 37 earnings per share for the quarter, beating the consensus estimate of N/A by 37.
Is Sofwave Medical Ltd. overvalued?
According to Wall Street analysts Sofwave Medical Ltd.’s price is currently Overvalued.
Does Sofwave Medical Ltd. pay dividends?
Sofwave Medical Ltd. does not currently pay dividends.
What is Sofwave Medical Ltd.’s EPS estimate?
Sofwave Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sofwave Medical Ltd. have?
Sofwave Medical Ltd. has 36,123,390 shares outstanding.
What happened to Sofwave Medical Ltd.’s price movement after its last earnings report?
Sofwave Medical Ltd. reported an EPS of 37 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.016%.
Which hedge fund is a major shareholder of Sofwave Medical Ltd.?
Currently, no hedge funds are holding shares in IL:SOFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sofwave Medical Ltd.
Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.